News Express
-
Science News: Anti-LGI4 Antibody Is a Novel Juxtaparanodal Autoantibody for Chronic Inflammatory Demyelinating Polyneuropathy
March 20, 2023
In this single-centered study, 113 anti-NF155 and anti-CNTN1 antibody–negative chronic inflammatory demyelinating polyneuropathy (CIDP) patients were enrolled and the reactivity of sera from these patients against mouse (dorsal root ganglion) DRG and sciatic nerves was surveyed. The objective of this was to identify novel nodal autoantibodies in CIDP.
-
Patient Safety: Percutaneous Sharp Injuries: Post-Exposure Procedures
March 19, 2023
From the AANEM Quality and Patient Safety Committee: Many healthcare workers, including some of 64% of electrodiagnostic (EDX) physicians who may have experienced a needlestick injury, are unfamiliar with proper post-exposure procedures following percutaneous sharp injury, leading to a greater risk of blood-borne pathogen seroconversion. Read more to learn about the proper post-exposure process.
-
Science News: Anti-titin Antibody Is Associated With More Frequent Hospitalization to Manage Thymoma-Associated Myasthenia Gravis
March 02, 2023
Anti-titin antibodies are anti-striational antibodies associated with thymoma-associated myasthenia gravis (MG). Anti-titin antibodies have been previously linked to severity of MG, but its relation to clinical worsening is not clear. Thus, the authors in this study aimed to evaluate whether the patients with anti-titin antibody are more frequently hospitalized to manage thymoma-associated MG than those patients without anti-titin antibody.
-
Science News: Virtual Charcot-Marie-Tooth Examination Score: A Validated Virtual Evaluation for People with Charcot-Marie-Tooth Disease.
February 19, 2023
The Charcot-Marie-Tooth (CMT) Examination Score Version 2 (CMTESv2) is used in clinical practice to measure impairment in patients with CMT. However, the CMTES requires an in-person visit, which may not be possible for all CMT patients. This study evaluated a virtual form of CMTES (vCMTES) as a remote clinical outcome assessment tool to measure impairment in CMT patients.
-
AANEM Endorsement of the 2023 ACC Expert Consensus Decision Pathway for Cardiac Amyloidosis
February 05, 2023
AANEM has recently endorsed the 2023 American College of Cardiology (ACC) Expert Consensus Decision Pathway for Cardiac Amyloidosis which became available online Monday, January 23, 2023 with the print copy published in the JACC print issue on March 21.
-
The Other Side of the Fence: Tips on Conducting Peer Reviews for Biomedical Journals
February 05, 2023
Join Muscle & Nerve Editor-in-Chief Zachary Simmons and Associate Editor Peter Kang for a live webinar and Q&A, The Other Side of the Fence: Tips on Conducting Peer Reviews for Biomedical Journals.
-
Science News: Ultrasonographic Prevalence of Ulnar Nerve Displacement at the Elbow in Young Baseball Players
February 05, 2023
Studies regarding ulnar nerve damage/displacement have been performed primarily in adults. The authors of this study assessed the ulnar nerve displacement in young baseball players.
-
Test your Knowledge: Question from Lessons from the Lab Episode 1
January 22, 2023
Test your Knowledge: Question from Lessons from the Lab Episode 1
-
AANEM Seeks Young Physician Alternate Delegate to AMA House of Delegates
January 18, 2023
Are you interested in policy-making, legislation, and scope of practice issues? AANEM is seeking a young physician to represent the association as both an Alternate Delegate and a Young Physician Section Delegate in the AMA House of Delegates. Apply by March 1, 2023.
-
Science News: Clinical Value of Cell-Based Assays in the Characterisation of Seronegative Myasthenia Gravis
January 18, 2023
Although autoantibody testing is critical for the diagnosis of myasthenia gravis (MG) in current clinical practice, the test can be negative in up to 10% of cases of generalized MG and up to 50% of cases of ocular MG.
-
Latest Anthology of Articles from the News Science Editorial Board Now Available
January 10, 2023
Each year, AANEM's News Science Editorial Board (NSEB) scours 40+ journals and write summaries of articles they find of value to them and other AANEM members. At the end of the year, they are compiled into a downloadable PDF for your convenience.
-
Science News: Relative Sit-to-Stand Muscle Power Predicts an Older Adult's Physical Independence at Age of 90 Yrs Beyond That of Relative Handgrip Strength, Physical Activity, and Sedentary Time: A Cross-sectional Analysis
January 05, 2023
Functional decline associated with advanced age results in significant morbidity and mortality, in addition to increased demand on healthcare systems. Models and testing to predict functional decline help healthcare systems direct resources to vulnerable individuals that are at risk of future loss of independence.
-
Science News: Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical Trial
December 19, 2022
There has been growing evidence that patients with myasthenia gravis (MG) can benefit from Rituximab therapy, particularly patients with refractory disease or MuSK antibody positive MG. However, there is no standardized protocol and hence it is a third-line treatment option in AChR antibody positive MG.
-
Science News: Ultrasound of Cervical Nerve Root Enlargement in Polyneuropathy is not Confounded by Neuroforaminal Stenosis
December 11, 2022
In this study, the authors aimed to investigate whether neuroforaminal cervical stenosis is associated with cervical root enlargements detectable by ultrasound.
-
Late-Onset Neuromuscular Disease Consortium Founded to Improve Care for Adults Across Neuromuscular Conditions
November 29, 2022
Recognizing an opportunity to better serve people living with rare neuromuscular conditions diagnosed in adulthood, the American Neuromuscular Foundation (ANF) founded the Late-Onset Neuromuscular Disease Consortium (LONDC) to facilitate collaboration across advocacy organizations, academia, clinical practice, industry, and other stakeholders.
-
Remembering George Kraft, MD, MS
November 20, 2022
AANEM Past President George Kraft, MD, MS, passed away on Tuesday, November 1, 2022.
-
Science News: Amyotrophic Lateral Sclerosis and Noninvasive Positive Pressure Ventilatory Support: "Nasal Noninvasive Ventilation" or "Noninvasive Ventilatory Support"?
November 13, 2022
This article proposes a trial of noninvasive ventilatory support as an alternative to tracheostomy in patients with amyotrophic lateral sclerosis (ALS). Studies have shown brief statistical benefit of nasal noninvasive ventilation; however, this strategy may not be able to normalize carbon dioxide (CO2), leading to hypercapnia and therefore eventually to CO2 narcosis, intubation, and tracheostomy.
-
CMS Finalizes Updates to Physician Fee Schedule
November 13, 2022
On November 1, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that includes updates to payment policies, payment rates, and quality provisions for services furnished under the Medicare Physician Payment Schedule effective January 1, 2023. AANEM policy staff is diligently reviewing the 3,000+ page rule. Read on for highlights.
-
Advocacy in Action: State Liaison Leads the Way for Patient Advocacy in Washington and Beyond
October 31, 2022
Mohammad A. Saeed, MD, MS, is one of AANEM’s longest-standing state liaisons and most active members. He’s gone above and beyond meeting with congressional members on his own and building key relationships to help move AANEM’s advocacy efforts forward. Dr. Saeed invited congresswomen Marilyn Strickland (D-WA) in May 2022 and Dr. Kim Schrier (D-WA) in October 2022 to town hall events at his home in Washington to discuss current issues and focuses of Congress with their supporters and guests.
-
Science News: Extensor Digitorum Brevis Bulk and Associations With Fibular Motor Nerve Conduction Amplitude
October 30, 2022
Prior studies demonstrate fibular compound motor action potential (CMAP) < 4.0 mV predicts impairment of ankle proprioceptive precision and increased fall risk. The authors posit that evaluation of extensor digitorum brevis (EDB) may present a simple surrogate for CMAP amplitude. This study aims to correlate physician evaluation of EDB muscle bulk with CMAP amplitude on nerve conduction study (NCS).